| Bioactivity | IL-17 modulator 1 (disodium) is an orally active, highly efficacious IL-17 modulator extracted from patent WO 2020127685. IL-17 modulator 1 (disodium) can be used for the research of diseases including psoriasis, ankylosing spondylitis and psoriatic arthritis[1]. | ||||||||||||
| Name | IL-17 modulator 1 disodium | ||||||||||||
| CAS | 2446803-91-2 | ||||||||||||
| Formula | C28H35N6Na2O6P | ||||||||||||
| Molar Mass | 628.57 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO 2020127685 |
IL-17 modulator 1 disodium
CAS: 2446803-91-2 F: C28H35N6Na2O6P W: 628.57
IL-17 modulator 1 (disodium) is an orally active, highly efficacious IL-17 modulator extracted from patent WO 2020127685
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.